Schedule 13G ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-024226
- Form type
- SC 13G
- Filer
- Kinnate Biopharma Inc.
- CIK
- CIK 1797768
- Filed
- Feb 16, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership